Search

Author/Creator Ponte, Jose F.

1. Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs). Issue 17 (1st September 2019)

Authors:
Reid, Emily E.; Archer, Katie E.; Shizuka, Manami; McShea, Molly A.; Maloney, Erin K.; Ab, Olga; Lanieri, Leanne; Wilhelm, Alan; Ponte, Jose F.; Yoder, Nicholas C.; Chari, Ravi V.J.; Miller, Michael L.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 17(2019)
Page Start:
2455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1 dose‐escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α‐targeting antibody‐drug conjugate, in patients with solid tumors. Issue 16 (25th April 2017)

Authors:
Moore, Kathleen N.; Borghaei, Hossein; O'Malley, David M.; Jeong, Woondong; Seward, Shelly M.; Bauer, Todd M.; Perez, Raymond P.; Matulonis, Ursula A.; Running, Kelli L.; Zhang, Xiaoyan; Ponte, Jose F.; Ruiz‐Soto, Rodrigo; Birrer, Michael J.
Journal:
Cancer
Issue:
Volume 123:Issue 16(2017)
Page Start:
3080
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search